Sarah J. Olmstead

Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity

Frontiers in Psychiatry January 10, 2023 Jennifer Warner-Schmidt, Christopher Pittenger, Martin Stogniew et al. 11 citations

Introduction Selective serotonin reuptake inhibitor (SSRI) antidepressants represent first-line pharmacological treatment for a variety of neuropsychiatric illnesses, including major depressive disorder (MDD), anxiety, and post-traumatic stress disorder (PTSD), which show high rates of comorbidity. SSRIs have a delayed onset of action. Most patients do not show significant effects until 4–8...